pfizer news - Search News

Pfizer names its head of oncology

Pfizer names oncology head Chris Boshoff as R&D chief

Pfizer has named company veteran Chris Boshoff, who led the drugmaker's cancer research and marketing for more than a year, as its R&D chief, WSJ reported on Wednesday.

The Wall Street Journal on MSN · 3d

Pfizer Names New R&D Chief

Company veteran Chris Boshoff, who has led Pfizer’s cancer research and marketing for more than a year, will become chief scientific officer starting Jan. 1.

STAT · 3d

Doubling down on its strategy, Pfizer names its head of oncology as new research chief

Pfizer, despite pressure from investors to look outside, elevates its cancer chief Chris Boshoff to lead overall R&D.

Pfizer, BridgeBio

Bloomberg on MSN · 1d

BridgeBio Gets US Approval for Heart Drug to Compete with Pfizer

BridgeBio Pharma Inc. gained US approval for a drug to treat a progressive and deadly form of heart disease, paving the way for the biotech company to go head-to-head with Pfizer Inc. in an increasingly competitive market.

BioSpace · 15h

BridgeBio Wins FDA Approval for ATTR-CM Drug, Launching Competition with Pfizer

BridgeBio secured approval for Attruby Friday, along with the all-important mortality benefit that could give the drug a significant boost in the market against Pfizer’s tafamidis and potentially Alnylam’s Amvuttra.

Reuters on MSN · 1d

US FDA approves BridgeBio's drug for rare heart condition

The U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said on Friday, making it the first new treatment in a market dominated by Pfizer's blockbuster Vyndaqel.

How Pfizer is trying to make U.S. healthcare easier to navigate

The pharma leader is betting that streamlined services may be a shot in the arm for Americans seeking care with its ...

Is Pfizer Stock A Sell With Vaccine Skeptic Robert F. Kennedy Jr. Tapped To Lead HHS?

Is Pfizer stock a sell after shares skidded on the news Trump selected Kennedy to take over HHS? Is PFE stock now a sell?

FierceBiotech3d

Pfizer plucks internal candidate to replace R&D head Dolsten, triggering series of leadership shakeups

Pfizer has found a successor for Chief Scientific Officer and R&D head Mikael Dolsten, M.D., Ph.D., tapping the company’s own ...

Pfizer Stock Drops 10% In November On News Of Kennedy's HHS Nomination

Pfizer shares are trading lower by 10% in November. President-elect Donald Trump last week announced his intention to nominate Robert F. Kennedy Jr. to lead the HHS.

Pfizer cannot recoup $75 million from SEC insider trading settlement, judge rules

A federal judge on Tuesday rejected Pfizer's bid to recoup about $75.2 million left over from a U.S. Securities and Exchange ...

FierceBiotech1d

Chutes & Ladders—Pfizer replaces retiring CSO with cancer chief

Pfizer has found a successor for retiring Chief Scientific Officer and R&D head Mikael Dolsten, M.D., Ph.D., tapping the ...

Pfizer promotes oncology chief to lead R&D as activist Starboard circles

Bourla said in a statement that Boshoff was “the ideal leader to propel Pfizer’s R&D engine forward and transform it into a world-leading organisation with a more focused strategy, driving the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Pfizer names its head of oncology

Pfizer, BridgeBio

Related topics